Neuroendocrine-related adverse events associated with antidepressant treatment in children and adolescents

CNS Neuroscience and Therapeutics

Volumn 16, Issue 2, 2010, Pages 83-90

  Jerrell, Jeanette M ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescents; Antidepressants; Children; Metabolic adverse events

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXAPRAM; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; ISOCARBOXAZID; MAPROTILINE; MIRTAZAPINE; MOOD STABILIZER; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRIMIPRAMINE; UNINDEXED DRUG; VENLAFAXINE;

ADOLESCENT; ANOREXIA; ARTICLE; CHILD; CHILD PSYCHIATRY; COMORBIDITY; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GASTROINTESTINAL SYMPTOM; GROUPS BY AGE; HUMAN; HYPERPROLACTINEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NAUSEA; NEUROENDOCRINE DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRESCHOOL CHILD; PRESCRIPTION; PREVALENCE; RACE DIFFERENCE; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; SEXUAL DYSFUNCTION; SIDE EFFECT; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION;

ADOLESCENT; AGE FACTORS; ANTIDEPRESSIVE AGENTS; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; ENDOCRINE SYSTEM DISEASES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENTAL DISORDERS; NEUROSECRETORY SYSTEMS; ODDS RATIO; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 77749286328     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2009.00106.x     Document Type: Article

References (27)

1. Costello EJ, Erkanli A, Angold A. Is there an epidemic of child or adolescent depression? J Child Psychol Psychiatry 2006 47 : 1263 1271.
2. McIntyre RS, Jerrell JM. Polypharmacy in children and adolescents with major depressive disorder. J Clin Psychiatry 2009 70 : 240 246.
3. Jerrell JM, McIntyre RS. Cardiovascular and neurological adverse events associated with antidepressant treatment in children and adolescents. J Child Neurol 2009 24 : 297 304.
4. McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH. The effect of antidepressants on glucose homeostasis and insulin sensitivity: Synthesis and mechanisms. Expert Opin Drug Safety 2006 5 : 157 168.
5. Baker S, Barlow S, Cochran W, Fuchs G, Klish W, Krebs N, Strauss R, Tershakovec A, Udall J. Overweight children and adolescents: A clinical report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenter Nutrition 2005 40 : 533 543.
6. Mancini T, Casanueva FF, Giustina A. Hyperprolactinemia and prolactinomas. Endocrinol Metab Clin N Am 2008 37 : 67 99.
7. McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH. The effect of antidepressants on lipid homeostasis: A cardiac safety concern. Expert Opin Drug Safety 2006 5 : 523 537.
8. Burke MJ, Lincoln J. Mood disorders. In : Bakel RE, ET Bope ET, editors. Conn's current therapy 2006. Philadelphia, PA : WB Saunders Co., 2006 1361 1370.
9. Cohen D, Gerardin P, Mazet P, Purper-Ouakil D, Flament MF. Pharmacological treatment of adolescent major depression. J Child Adolesc Psychopharm 2004 14 : 19 31.
10. Hu XH, Bull SA, Hunkeler EM, Ming E, Lee JY, Fireman B, Markson LE. Incidence and duration of side effects and those rated as bothersome with SSRI treatment for depression: Patient report versus physician estimate. J Clin Psychiatry 2004 65 : 959 965.
11. Masand PS, Gupta S. Long-term side effects of newer-generation antidepressants: SSRIs, venlafaxine, nefazodone, bupropion, and mirtazapine. Ann Clin Psychiatry 2002 14 : 175 182.
12. Hirschfeld RMA. The role of atypical antipsychotics in the treatment of bipolar disorder. J Clin Psychiatry 2005 66 (Suppl 3 3 4.
13. Gold Standard, Inc. Citalopram, Escitalopram, Fluoxetine, Fluoxetine+Olanzapine, Fluvoxamine, Paroxetine, and Sertraline: Adverse reactions. MD Consult [database] 2008. Columbia, SC : University of South Carolina School of Medicine Library, Accessed January 30, 2008.
14. Chen JL, Spinowitz N, Karwa M. Hypertriglyceridemia, acute pancreatitis, and diabetic ketoacidosis possible associate with mirtazapine: a case report. Pharmacotherapy 2003 23 : 940 944.
15. Damsa C, Bumb A, Bianchi-Demicheli F, Vidailhet P, Sterck R, Andreoli A, Beyenburg S. "Dopamine dependent" side effects of SSRIs: A clinical review. J Clin Psychiatry 2004 65 : 1064 1068.
16. Ellsworth AJ, Witt DM, Dugdale DC, Oliver L. Mosby's medical drug reference. St. Louis, MO : Mosby, 2006.
17. McIntyre RS, Konarski JZ. Tolerability profiles of atypical antipsychotics in the treatment of bipolar disorder. J Clin Psychiatry 2005 66 (Suppl 3 28 36.
18. Cheng-Shannon J, McGough JJ, Pataki C, McCracken JT. Second generation antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol 2004 14 : 372 394.
19. Correll CU. Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: A systematic review and pooled analysis of short-term trials. J Acad Child Adolesc Psychiatry 2007 46 : 687 700.
20. Correll CU, Carlson HE. Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. J Am Acad Child Adolesc Psychiatry 2006 45 : 771 791.
21. Correll CU, Penzner JB, Parikh UH, Mughal T, Javed T, Carbon M, Malhotra AK. Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents. Child Adolesc Psychiatric Clin N Am 2006 15 : 177 206.
22. Fedorowicz VJ, Fombonne E. Metabolic side effects of atypical antipsychotics in children: A literature review. J Psychopharmacol 2005 9 : 533 550.
23. Findling RL, Steiner H, Weller EB. Use of antipsychotics in children and adolescents. J Clin Psychiatry 2005 66 (Suppl 7 29 40.
24. Goodnick PJ, Rodriguez L, Santana O. Antipsychotics: Impact on prolactin levels. Expert Opin Pharmacotherapy 2002 3 : 1381 1391.
25. Kim KS, Pae CU, Chae JH, Bahk WM, Jun TY, Kim DJ, Dickson RA. Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone. J Clin Psychiatry 2002 63 : 408 413.
26. Holmberg SK, Kane C. Health and self-care practices of persons with schizophrenia. Psychiatr Serv 1999 50 : 827 829.
27. Mark TL, Buck JA, Dilonardo JD, Coffey RM, Chalk M. Medicaid expenditures on behavioral health care. Psychiatr Serv 2003 54 : 188 194.